Karen A. Cashmere
2023
In 2023, Karen A. Cashmere earned a total compensation of $486.7K as Chief Commercial Officer at ZyVersa Therapeutics, a 16% decrease compared to previous year.
Compensation breakdown
| Bonus | $90,000 |
|---|---|
| Option Awards | $76,687 |
| Salary | $320,000 |
| Total | $486,687 |
Cashmere received $320K in salary, accounting for 66% of the total pay in 2023.
Cashmere also received $90K in bonus and $76.7K in option awards.
Rankings
In 2023, Karen A. Cashmere's compensation ranked 1,886th out of 2,615 executives tracked by ExecPay. In other words, Cashmere earned more than 27.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,886 out of 2,615 | 28th |
Division Manufacturing | 1,070 out of 1,425 | 25th |
Major group Chemicals And Allied Products | 654 out of 801 | 18th |
Industry group Drugs | 637 out of 767 | 17th |
Industry Pharmaceutical Preparations | 447 out of 542 | 18th |
Source: SEC filing on September 9, 2024.
Cashmere's colleagues
We found two more compensation records of executives who worked with Karen A. Cashmere at ZyVersa Therapeutics in 2023.